indazoles has been researched along with Synovioma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Caldari, E; De Paolis, M; Fiore, M; Giannini, C; Pirini, MG; Sambri, A; Spinnato, P; Zucchini, R | 1 |
| Acar, R; Akgul, F; Artac, M; Aydin, SG; Bahceci, A; Besiroglu, M; Bilici, A; Cinkir, HY; Dal, P; Demir, H; Demiray, AG; Derin, S; Eraslan, E; Erdem, D; Ergun, Y; Erol, C; Goksu, SS; Guc, ZG; Gumusay, O; Gunaydin, UM; Kaplan, MA; Karaagac, M; Karaca, M; Koca, S; Koral, L; Menekse, S; Ocak, B; Ozkul, O; Ozveren, A; Ozyukseler, DT; Paydas, S; Sahin, S; Sakalar, T; Sakin, A; Seker, MM; Sunar, V; Turhal, S; Unal, OU; Yekeduz, E | 1 |
| Antonescu, CR; Bandlamudi, C; Chi, P; D'Angelo, SP; Dickson, M; Donoghue, M; Gounder, M; Kelly, C; Keohan, ML; Movva, S; Nacev, B; Qin, LX; Rosenbaum, E; Seier, K; Simeone, N; Slotkin, EK; Tap, WD | 1 |
| Endo, M; Fukushi, JI; Fukushima, S; Hatano, M; Iwamoto, Y; Matsumoto, Y; Matsunobu, T; Nabeshima, A; Okada, S; Yokoyama, N | 1 |
| Araki, N; Hamada, K; Imura, Y; Itoh, K; Kaneko, K; Myoui, A; Naka, N; Nakai, S; Nakai, T; Outani, H; Takenaka, S; Ueda, T; Yamada, S; Yasuda, N; Yoshikawa, H | 1 |
| Benson, C; Freivogel, KW; Gelderblom, H; Grignani, G; Jobanputra, M; Judson, IR; Katz, D; Manson, SC; Merimsky, O; Mungul, A; Sanfilippo, R; Stein, D | 1 |
| Kondo, T; Ochiya, T; Shiozawa, K; Shuting, J; Yoshioka, Y | 1 |
| Desar, IME; Fleuren, EDG; van der Graaf, WTA | 1 |
| Kondo, T; Ochiya, T; Qiao, Z; Shiozawa, K; Shuting, J; Yoshioka, Y | 1 |
| Dry, SM; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kawaguchi, K; Kimura, H; Kiyuna, T; Li, Y; Miwa, S; Miyake, K; Miyake, M; Nelson, SD; Russell, TA; Singh, SR; Tsuchiya, H; Yamamoto, N | 1 |
| Ferrari, S; Paioli, A; Palmerini, E | 1 |
| van der Graaf, WT; van Erp, NP; Vlenterie, M | 1 |
| Asai, K; Eguchi, Y; Hirata, K; Kawaguchi, T; Kojima, K; Ohsawa, M; Sugitani, A | 1 |
| Ledoux, B; Petit, B; Seront, E; van Marcke, C | 1 |
| Araki, N; Boku, S; Goto, T; Hiraga, H; Honoki, K; Kawai, A; Matsumine, A; Nakamura, T; Nishida, Y; Sudo, A; Sugiura, H; Ueda, T; Yasuda, T; Yonemoto, T | 1 |
| Basso, E; Bergamaschi, L; Carta, R; Casanova, M; Chiaravalli, S; Fagioli, F; Ferrari, A; Magni, C; Massimino, M; Tirtei, E | 1 |
| Chiba, K; Horiuchi, K; Hosaka, S; Morioka, H; Nakamura, M; Nakayama, R; Susa, M; Tohmonda, T; Toyama, Y; Yoda, M | 1 |
3 review(s) available for indazoles and Synovioma
| Article | Year |
|---|---|
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.
Topics: Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Epigenomics; Gene Expression Regulation, Neoplastic; Genomics; Humans; Ifosfamide; Indazoles; Molecular Targeted Therapy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Soft Tissue Neoplasms; Sulfonamides; Surgical Procedures, Operative; Trabectedin | 2021 |
Systemic Treatment for Adults with Synovial Sarcoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Indazoles; Pyrimidines; Sarcoma, Synovial; Sulfonamides; Trabectedin | 2018 |
Emerging therapeutic targets for synovial sarcoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bevacizumab; Everolimus; Humans; Indazoles; Indoles; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sarcoma; Sarcoma, Synovial; Sirolimus; Sorafenib; Sulfonamides; Sunitinib; TOR Serine-Threonine Kinases | 2014 |
14 other study(ies) available for indazoles and Synovioma
| Article | Year |
|---|---|
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Topics: Adult; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Turkey | 2023 |
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Child; Disease-Free Survival; Female; Genotype; HLA-A Antigens; Humans; Indazoles; Loss of Heterozygosity; Male; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Prognosis; Pyrimidines; Sarcoma, Synovial; Sulfonamides; T-Lymphocytes; Treatment Outcome; Young Adult | 2020 |
Activation of ERK1/2 Causes Pazopanib Resistance via Downregulation of DUSP6 in Synovial Sarcoma Cells.
Topics: Animals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 6; Female; Humans; Indazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Pyridones; Pyrimidines; Pyrimidinones; ras Proteins; Sarcoma, Synovial; Sulfonamides | 2017 |
Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Humans; Indazoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Pyrimidines; Quinolines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma, Synovial; Signal Transduction; Sulfonamides; Thiourea; Xenograft Model Antitumor Assays | 2017 |
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
Topics: Angiogenesis Inhibitors; Compassionate Use Trials; Disease-Free Survival; Female; Hemangiosarcoma; Humans; Indazoles; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Pyrimidines; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Solitary Fibrous Tumors; Sulfonamides; Survival Rate; Time Factors; Uterine Neoplasms | 2017 |
Extracellular vesicle-encapsulated microRNA-761 enhances pazopanib resistance in synovial sarcoma.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Extracellular Vesicles; Humans; Indazoles; Lamin Type A; LIM Domain Proteins; MicroRNAs; Pyrimidines; Sarcoma, Synovial; Sirtuin 3; Sulfonamides; Transcription Factors | 2018 |
Pazopanib-induced changes in protein expression signatures of extracellular vesicles in synovial sarcoma.
Topics: Cell Line, Tumor; Culture Media, Conditioned; Extracellular Vesicles; Humans; Indazoles; Neoplasm Proteins; Proteomics; Pyrimidines; Sarcoma, Synovial; Signal Transduction; Sulfonamides | 2018 |
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.
Topics: Animals; Doxorubicin; Drug Resistance, Neoplasm; Humans; Indazoles; Male; Mice; Mice, Nude; Middle Aged; Pyrimidines; Sarcoma, Synovial; Sulfonamides; Xenograft Model Antitumor Assays | 2019 |
Promising management of pazopanib-induced liver toxicity.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Pyrimidines; Salvage Therapy; Sarcoma, Synovial; Sulfonamides | 2015 |
Primary Pleural Synovial Sarcoma Treated with Pazopanib.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Doxorubicin; Dyspnea; Fatal Outcome; Female; Humans; Ifosfamide; Indazoles; Neoplasm Recurrence, Local; Pleural Effusion, Malignant; Pleural Neoplasms; Pyrimidines; Sarcoma, Synovial; Sulfonamides | 2015 |
Rapid and fatal acute heart failure induced by pazopanib.
Topics: Antineoplastic Agents; Dyspnea; Fatal Outcome; Fatigue; Female; Heart Failure; Humans; Indazoles; Middle Aged; Pyrimidines; Sarcoma, Synovial; Sulfonamides; Thoracic Neoplasms | 2015 |
The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemical and Drug Induced Liver Injury; Disease-Free Survival; Female; Fibrosarcoma; Humans; Hypertension; Indazoles; Japan; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Pneumothorax; Product Surveillance, Postmarketing; Pyrimidines; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Sulfonamides; Survival Analysis; Thrombocytopenia | 2016 |
Response to pazopanib in two pediatric patients with pretreated relapsing synovial sarcoma.
Topics: Adolescent; Angiogenesis Inhibitors; Female; Humans; Indazoles; Male; Pyrimidines; Recurrence; Sarcoma, Synovial; Sulfonamides | 2017 |
A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway.
Topics: Animals; Cell Line, Tumor; G1 Phase; Humans; Indazoles; Mice; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor Protein-Tyrosine Kinases; Sarcoma, Synovial; Signal Transduction; Sulfonamides; Xenograft Model Antitumor Assays | 2012 |